Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02992340
Status:
TERMINATED
Last Update Posted:
2021-01-14
First Post:
2016-12-08
Brief Title:
Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC
Sponsor:
ASLAN Pharmaceuticals
Organization:
ASLAN Pharmaceuticals
Organization Data
Organization:
ASLAN Pharmaceuticals
Class:
OTHER
Study ID:
ASLAN001-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ASLAN Pharmaceuticals
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None